"Expect to grow", personally and professionally: At Siegfried, we offer exciting challenges and ample opportunities to showcase your talents.
As a trusted and respected partner to the pharmaceutical industry, we uphold the highest standards in safety, quality and sustainability, while fostering a culture that empowers you to thrive.
Join a rapidly expanding global company, where diverse perspectives and experiences come together in a collaborative environment.
Description
"Expect to grow", personally and professionally: At Siegfried, we offer exciting challenges and ample opportunities to showcase your talents.
As a trusted and respected partner to the pharmaceutical industry, we uphold the highest standards in safety, quality and sustainability, while fostering a culture that empowers you to thrive.
Join a rapidly expanding global company, where diverse perspectives and experiences come together in a collaborative environment.
This page reviews the Global Head Drug Product Development & Technology opportunity at Siegfried in Zofingen (administration sector), with a focus on the tax implications for cross-border workers in the Canton of Argovia.
Accepting this offer from Siegfried means obtaining a cross-border G Permit. The Canton of Argovia withholds tax on gross salary; new cross-border workers since 2024 fall under the New Tax Agreement with concurrent taxation.
Swiss social contributions include AVS (5.3%), unemployment insurance (1.1%) and LPP (occupational pension). Use our free tax simulator to estimate the net salary for Global Head Drug Product Development & Technology in administration and compare the cost of living between Switzerland and Italy.
Frequently asked questions
What net pay can you expect for the Global Head Drug Product Development & Technology role (administration) in Argovia?
The Global Head Drug Product Development & Technology role (administration) in Zofingen is taxed at source by the Canton of Argovia plus AVS/LPP contributions. Run the simulator with the real figures of Siegfried.
LAMal or Italian insurance: which should you pick for the Global Head Drug Product Development & Technology (administration) role?
The Global Head Drug Product Development & Technology role in Zofingen requires choosing between LAMal (mandatory for new cross-border workers since 2024) and the right of option. Compare premiums with our LAMal comparator.
